Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy.

Current oncology reports - 15 Apr 2021

Lin Yuan-Mao, Taiji Ryosuke, Calandri Marco, Odisio Bruno C

Abstract excerpt

PURPOSE OF REVIEW: Interventional oncology (IO) loco-regional treatments are widely utilized in clinical practice. However, local tumor control rates are still widely variable. There is a need to identify and develop novel biomarkers prognosticators following IO therapies. Here, we review the current literature on molecular tumor biomarkers in IO, mainly focusing on patients with liver and lung cancers. RECENT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Hepatocellular
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Ki-67 Antigen

Share to Liver Neoplasms

Share to Lung Neoplasms

Share to Medical Oncology

Source

Identifiers

PMID: 33855606
DOI: 10.1007/s11912-021-01056-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy.PMID 33855606Read ↗

Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making.Semantic proximity Read ↗

Innovation and Future Perspectives in the Treatment of Colorectal Liver Metastases.Semantic proximity Read ↗

Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.Semantic proximity Read ↗

Combating colorectal lung metastases via systemic therapy and thermal ablation: RAS mutation impact.Semantic proximity Read ↗

RAS mutation nomograms to predict prognosis after radiofrequency ablation of recurrent colorectal liver metastasesSemantic proximity Read ↗

KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.Semantic proximity Read ↗

RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.Semantic proximity Read ↗

Tumor-liver interface in MRI of liver metastasis enables prediction of EGFR mutation in patients with lung cancer: A proof-of-concept study.Semantic proximity Read ↗

Prospective analysis of the effects of RAS mutation on local tumor progression and overall survival after radiofrequency ablation for colorectal liver metastases.Semantic proximity Read ↗

Pretreatment KRAS-Mutant Circulating Tumor DNA Predicts Incidence and Patterns of Recurrence in Patients Undergoing Radiofrequency Ablation for Colorectal Liver Metastases: A Prospective Analysis.Semantic proximity Read ↗

Integrated radiomics and machine learning approach for ras mutation status prediction in colorectal liver metastases.Semantic proximity Read ↗

Connecting cancer biology and clinical outcomes to imaging in KRAS mutant and wild-type colorectal cancer liver tumors following selective internal radiation therapy with yttrium-90.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.